stockrowEdwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.
- Revenue
- +10.5%
- EPS
- +6.00%
- Free cash flow
- −1.84%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow EW
Alert me
Edwards Lifesciences Corporation (EW) Net income
Edwards Lifesciences Corporation's net income for fiscal 2025 was $1.1B, down 74.4% from $4.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.0B. Over the past ten years it has ranged from $494.9M (fiscal 2015) to $4.2B (fiscal 2024); the current reading is higher than 64% of that period. Edwards Lifesciences Corporation ranks 8th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.1B | (74.35%) |
| FY2024 | $4.2B | 197.96% |
| FY2023 | $1.4B | (8.05%) |
| FY2022 | $1.5B | 1.25% |
| FY2021 | $1.5B | 82.55% |
| FY2020 | $823.4M | (21.35%) |
| FY2019 | $1.0B | 44.96% |
| FY2018 | $722.2M | 23.75% |
| FY2017 | $583.6M | 2.48% |
| FY2016 | $569.5M | 15.07% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $301.4M | 24.86% |
| Jun 2026 | $241.4M | (36.59%) |
| Mar 2026 | $380.7M | 317.43% |
| Dec 2025 | $91.2M | (68.58%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| MDT Medtronic PLC compare | $5.3B |
| SYK Stryker Corporation compare | $3.6B |
| BSX Boston Scientific Corporation compare | $3.5B |
| GEHC GE HealthCare Technologies Inc. compare | $2.2B |
| PHG Koninklijke Philips N.V. compare | $1.1B |
| EW Edwards Lifesciences Corporation | $1.0B |
| DXCM DexCom, Inc. compare | $991.0M |
| STE STERIS plc compare | $829.8M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $768.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on EW
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement